GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » YIFAN PHARMACEUTICAL CO LTD (SZSE:002019) » Definitions » Cash Flow from Investing

YIFAN PHARMACEUTICAL CO (SZSE:002019) Cash Flow from Investing : ¥-571 Mil (TTM As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is YIFAN PHARMACEUTICAL CO Cash Flow from Investing?

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the three months ended in Mar. 2024, YIFAN PHARMACEUTICAL CO spent ¥132 Mil on purchasing property, plant, equipment. It gained ¥1 Mil from selling property, plant, and equipment. It spent ¥0 Mil on purchasing business. It gained ¥5 Mil from selling business. It spent ¥15 Mil on purchasing investments. It gained ¥65 Mil from selling investments. It paid ¥0Mil for net Intangibles purchase and sale. And it received ¥0 Mil from other investing activities. In all, YIFAN PHARMACEUTICAL CO spent ¥76 Mil on investment activities in financial market and operating subsidiaries for the three months ended in Mar. 2024.


YIFAN PHARMACEUTICAL CO Cash Flow from Investing Historical Data

The historical data trend for YIFAN PHARMACEUTICAL CO's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YIFAN PHARMACEUTICAL CO Cash Flow from Investing Chart

YIFAN PHARMACEUTICAL CO Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Investing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,586.46 -770.55 -507.89 -670.17 -532.84

YIFAN PHARMACEUTICAL CO Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow from Investing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -38.31 62.04 -18.28 -538.29 -76.27

YIFAN PHARMACEUTICAL CO Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

YIFAN PHARMACEUTICAL CO's Cash Flow from Investing for the fiscal year that ended in Dec. 2023 is calculated as:

YIFAN PHARMACEUTICAL CO's Cash Flow from Investing for the quarter that ended in Mar. 2024 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-571 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


YIFAN PHARMACEUTICAL CO  (SZSE:002019) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

YIFAN PHARMACEUTICAL CO's purchase of property, plant, equipment for the three months ended in Mar. 2024 was ¥-132 Mil. It means YIFAN PHARMACEUTICAL CO spent ¥132 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

YIFAN PHARMACEUTICAL CO's sale of property, plant, equipment for the three months ended in Mar. 2024 was ¥1 Mil. It means YIFAN PHARMACEUTICAL CO gained ¥1 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

YIFAN PHARMACEUTICAL CO's purchase of business for the three months ended in Mar. 2024 was ¥0 Mil. It means YIFAN PHARMACEUTICAL CO spent ¥0 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

YIFAN PHARMACEUTICAL CO's sale of business for the three months ended in Mar. 2024 was ¥5 Mil. It means YIFAN PHARMACEUTICAL CO gained ¥5 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

YIFAN PHARMACEUTICAL CO's purchase of investment for the three months ended in Mar. 2024 was ¥-15 Mil. It means YIFAN PHARMACEUTICAL CO spent {stock_data.stock.currency_symbol}}15 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

YIFAN PHARMACEUTICAL CO's sale of investment for the three months ended in Mar. 2024 was ¥65 Mil. It means YIFAN PHARMACEUTICAL CO gained ¥65 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

YIFAN PHARMACEUTICAL CO's net Intangibles purchase and sale for the three months ended in Mar. 2024 was ¥0 Mil. It means YIFAN PHARMACEUTICAL CO paid ¥0 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

YIFAN PHARMACEUTICAL CO's cash from discontinued investing activities for the three months ended in Mar. 2024 was 0 Mil. It means YIFAN PHARMACEUTICAL CO paid ¥0 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

YIFAN PHARMACEUTICAL CO's cash from other investing activities for the three months ended in Mar. 2024 was ¥0 Mil. It means YIFAN PHARMACEUTICAL CO received ¥0 Mil from other investing activities.


YIFAN PHARMACEUTICAL CO Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of YIFAN PHARMACEUTICAL CO's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.


YIFAN PHARMACEUTICAL CO (SZSE:002019) Business Description

Traded in Other Exchanges
N/A
Address
No. 50 Qinshan, Jincheng, Lin'an Economic Development Zone, Hangzhou, Zhejiang, CHN, 311300
YIFAN PHARMACEUTICAL CO LTD is a China-based company engaged in pharmaceutical innovation and manufacturing. The company focuses its activities on key areas like macromolecular biologics, high-value pharmaceuticals, and differentiated traditional Chinese medicines. The products of the company are F-627 for Neutropenia and Parkinson's disease, F-652 for acute alcoholic hepatitis, GvHD and acute pancreatitis and F-899 for growth deficiency. The company's products are sold in China and internationally.
Executives
Ye Yi Qun Director
Zhang Da Wei Executives
Geng Yu Hong Executives
Feng De Qi Directors, Directors, and Executives
Zhou Ben Yu Director
Lin Xing Directors, executives
Yu Hai Xia Executives
Cheng Xian Feng Directors, executives
Xu Guo Han Supervisors
Cao Shi Mei Director
Lin Guan Yu Director
Zhang Lian Chun Executives
Guo Xin Fu Director
Zheng Shi Ming Supervisors
Yin Hang Hua Executives

YIFAN PHARMACEUTICAL CO (SZSE:002019) Headlines

No Headlines